Evercore is an independent investment bank focused on advisory work rather than balance-sheet lending. It advises corporations, sponsors and governments on mergers and acquisitions, restructurings, capital raising and related strategic transactions, and also offers equities research, sales and trading. The firm competes as a premier boutique against bulge-bracket banks by emphasizing senior banker attention and conflict-light advice.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 833.8 | — | 97.2 | 39.4% |
| Q3 2025 | 1,038.9 | — | 144.6 | 82.9% |
| Q4 2025 | 1,288.3 | — | 203.9 | 57.1% |
| Q1 2026 | 1,391.6 | — | 301.2 | 120.6% |
| Q2 2026 | 990.2 | 18.8% | 95.3 | -2% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Bio-Rad Laboratories, Inc. (BIO B), Glaukos Corporation (GKOS), Companhia Energética de Minas Gerais - CEMIG (CIG C), Darling Ingredients Inc. (DAR), Advanced Drainage Systems, Inc. (WMS), Cullen/Frost Bankers, Inc. (CFR)